Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
Biochim Biophys Acta ; 1840(9): 2851-61, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24821014

ABSTRACT

BACKGROUND: Gram-positive bacteria in the phylum Firmicutes synthesize the low molecular weight thiol bacillithiol rather than glutathione or mycothiol. The bacillithiol transferase YfiT from Bacillus subtilis was identified as a new member of the recently discovered DinB/YfiT-like Superfamily. Based on structural similarity using the Superfamily program, we have determined 30 of 31 Staphylococcus aureus strains encode a single bacillithiol transferase from the DinB/YfiT-like Superfamily, while the remaining strain encodes two proteins. METHODS: We have cloned, purified, and confirmed the activity of a recombinant bacillithiol transferase (henceforth called BstA) encoded by the S. aureus Newman ORF NWMN_2591. Moreover, we have studied the saturation kinetics and substrate specificity of this enzyme using in vitro biochemical assays. RESULTS: BstA was found to be active with the co-substrate bacillithiol, but not with other low molecular weight thiols tested. BstA catalyzed bacillithiol conjugation to the model substrates monochlorobimane, 1-chloro-2,4-dinitrobenzene, and the antibiotic cerulenin. Several other molecules, including the antibiotic rifamycin S, were found to react directly with bacillithiol, but the addition of BstA did not enhance the rate of reaction. Furthermore, cells growing in nutrient rich medium exhibited low BstA activity. CONCLUSIONS: BstA is a bacillithiol transferase from S. aureus that catalyzes the detoxification of cerulenin. Additionally, we have determined that bacillithiol itself might be capable of directly detoxifying electrophilic molecules. GENERAL SIGNIFICANCE: BstA is an active bacillithiol transferase from S. aureus Newman and is the first DinB/YfiT-like Superfamily member identified from this organism. Interestingly, BstA is highly divergent from B. subtilis YfiT.


Subject(s)
Bacterial Proteins , Cerulenin/chemistry , Dinitrochlorobenzene/chemistry , Pyrazoles/chemistry , Staphylococcus aureus/enzymology , Transferases , Bacillus subtilis/enzymology , Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Catalysis , Substrate Specificity , Transferases/chemistry , Transferases/isolation & purification
2.
Mol Microbiol ; 88(3): 577-89, 2013 May.
Article in English | MEDLINE | ID: mdl-23560716

ABSTRACT

Bacteriophages represent a majority of all life forms, and the vast, dynamic population with early origins is reflected in their enormous genetic diversity. A large number of bacteriophage genomes have been sequenced. They are replete with novel genes without known relatives. We know little about their functions, which genes are required for lytic growth, and how they are expressed. Furthermore, the diversity is such that even genes with required functions - such as virion proteins and repressors - cannot always be recognized. Here we describe a functional genomic dissection of mycobacteriophage Giles, in which the virion proteins are identified, genes required for lytic growth are determined, the repressor is identified, and the transcription patterns determined. We find that although all of the predicted phage genes are expressed either in lysogeny or in lytic growth, 45% of the predicted genes are non-essential for lytic growth. We also describe genes required for DNA replication, show that recombination is required for lytic growth, and that Giles encodes a novel repressor. RNAseq analysis reveals abundant expression of a small non-coding RNA in a lysogen and in late lytic growth, although it is non-essential for lytic growth and does not alter lysogeny.


Subject(s)
DNA Replication , Gene Expression Regulation, Viral , Genes, Essential , Genome, Viral , Mycobacteriophages/genetics , Virus Replication , Chromatography, Liquid , Gene Deletion , Lysogeny , Mycobacteriophages/physiology , Mycobacterium smegmatis/virology , Promoter Regions, Genetic , RNA, Small Untranslated/genetics , Repressor Proteins , Tandem Mass Spectrometry , Transcription, Genetic , Viral Proteins/genetics
3.
Proc Natl Acad Sci U S A ; 107(14): 6482-6, 2010 Apr 06.
Article in English | MEDLINE | ID: mdl-20308541

ABSTRACT

Bacillithiol (BSH), the alpha-anomeric glycoside of L-cysteinyl-D-glucosamine with L-malic acid, is a major low-molecular-weight thiol in Bacillus subtilis and related bacteria. Here, we identify genes required for BSH biosynthesis and provide evidence that the synthetic pathway has similarities to that established for the related thiol (mycothiol) in the Actinobacteria. Consistent with a key role for BSH in detoxification of electrophiles, the BshA glycosyltransferase and BshB1 deacetylase are encoded in an operon with methylglyoxal synthase. BshB1 is partially redundant in function with BshB2, a deacetylase of the LmbE family. Phylogenomic profiling identified a conserved unknown function protein (COG4365) as a candidate cysteine-adding enzyme (BshC) that co-occurs in genomes also encoding BshA, BshB1, and BshB2. Additional evolutionarily linked proteins include a thioredoxin reductase homolog and two thiol:disulfide oxidoreductases of the DUF1094 (CxC motif) family. Mutants lacking BshA, BshC, or both BshB1 and BshB2 are devoid of BSH. BSH is at least partially redundant in function with other low-molecular-weight thiols: redox proteomics indicates that protein thiols are largely reduced even in the absence of BSH. At the transcriptional level, the induction of genes controlled by two thiol-based regulators (OhrR, Spx) occurs normally. However, BSH null cells are significantly altered in acid and salt resistance, sporulation, and resistance to electrophiles and thiol reactive compounds. Moreover, cells lacking BSH are highly sensitive to fosfomycin, an epoxide-containing antibiotic detoxified by FosB, a prototype for bacillithiol-S-transferase enzymes.


Subject(s)
Bacillus subtilis/metabolism , Cysteine/analogs & derivatives , Glucosamine/analogs & derivatives , Bacillus subtilis/drug effects , Bacillus subtilis/genetics , Cysteine/biosynthesis , Cysteine/chemistry , Disulfides/metabolism , Drug Resistance, Bacterial , Fosfomycin/pharmacology , Genome, Bacterial , Glucosamine/biosynthesis , Glucosamine/chemistry , Glycosyltransferases/metabolism , Molecular Structure , Molecular Weight , Multigene Family , Mutation , Oxidative Stress , Phylogeny , Stress, Physiological
4.
Microbiology (Reading) ; 158(Pt 4): 1117-1126, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22262099

ABSTRACT

Bacillithiol (BSH), an α-anomeric glycoside of l-cysteinyl-d-glucosaminyl-l-malate, is a major low-molecular-mass thiol found in bacteria such as Bacillus sp., Staphylococcus aureus and Deinococcus radiodurans. Like other low-molecular-mass thiols such as glutathione and mycothiol, BSH is likely to be involved in protection against environmental toxins including thiol-reactive antibiotics. We report here a BSH-dependent detoxification mechanism in S. aureus. When S. aureus Newman strain was treated with monobromobimane and monochlorobimane, the cellular BSH was converted to the fluorescent S-conjugate BS-bimane. A bacillithiol conjugate amidase activity acted upon the BS-bimane to produce Cys-bimane, which was then acetylated by an N-acetyltransferase to generate N-acetyl-Cys-bimane, a mercapturic acid. An S. aureus mutant lacking BSH did not produce mercapturic acid when treated with monobromobimane and monochlorobimane, confirming the involvement of bacillithiol. Furthermore, treatment of S. aureus Newman with rifamycin, the parent compound of the first-line anti-tuberculosis drug, rifampicin, indicated that this thiol-reactive antibiotic is also detoxified in a BSH-dependent manner, since mercapturic acids of rifamycin were observed in the culture medium. These data indicate that toxins and thiol-reactive antibiotics are detoxified to less potent mercapturic acids in a BSH-dependent manner and then exported out of the cell in S. aureus.


Subject(s)
Cysteine/analogs & derivatives , Glucosamine/analogs & derivatives , Staphylococcus aureus/metabolism , Acetylcysteine/metabolism , Acetyltransferases/metabolism , Amidohydrolases/metabolism , Bridged Bicyclo Compounds/pharmacology , Cysteine/metabolism , Glucosamine/metabolism , Pyrazoles/pharmacology , Rifamycins/pharmacology , Sequence Deletion , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Sulfhydryl Compounds/metabolism
5.
J Bacteriol ; 193(8): 1981-90, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21335456

ABSTRACT

The mshA::Tn5 mutant of Mycobacterium smegmatis does not produce mycothiol (MSH) and was found to markedly overproduce both ergothioneine and an ~15-kDa protein determined to be organic hydroperoxide resistance protein (Ohr). An mshA(G32D) mutant lacking MSH overproduced ergothioneine but not Ohr. Comparison of the mutant phenotypes with those of the wild-type strain indicated the following: Ohr protects against organic hydroperoxide toxicity, whereas ergothioneine does not; an additional MSH-dependent organic hydroperoxide peroxidase exists; and elevated isoniazid resistance in the mutant is associated with both Ohr and the absence of MSH. Purified Ohr showed high activity with linoleic acid hydroperoxide, indicating lipid hydroperoxides as the likely physiologic targets. The reduction of oxidized Ohr by NADH was shown to be catalyzed by lipoamide dehydrogenase and either lipoamide or DlaT (SucB). Since free lipoamide and lipoic acid levels were shown to be undetectable in M. smegmatis, the bound lipoyl residues of DlaT are the likely source of the physiological dithiol reductant for Ohr. The pattern of occurrence of homologs of Ohr among bacteria suggests that the ohr gene has been distributed by lateral transfer. The finding of multiple Ohr homologs with various sequence identities in some bacterial genomes indicates that there may be multiple physiologic targets for Ohr proteins.


Subject(s)
Bacterial Proteins/metabolism , Biosynthetic Pathways/genetics , Cysteine/biosynthesis , Ergothioneine/metabolism , Glycopeptides/biosynthesis , Inositol/biosynthesis , Mycobacterium smegmatis/drug effects , Antitubercular Agents/metabolism , DNA Transposable Elements , Drug Resistance, Bacterial , Hydrogen Peroxide/toxicity , Isoniazid/metabolism , Microbial Viability/drug effects , Mutagenesis, Insertional , Mycobacterium smegmatis/genetics
6.
Biochemistry ; 50(49): 10751-60, 2011 Dec 13.
Article in English | MEDLINE | ID: mdl-22059487

ABSTRACT

The superfamily of glutathione S-transferases has been the subject of extensive study; however, Actinobacteria produce mycothiol (MSH) in place of glutathione, and no mycothiol S-transferase (MST) has been identified. Using mycothiol and monochlorobimane as substrates, an MST activity was detected in extracts of Mycobacterium smegmatis and purified sufficiently to allow identification of MSMEG_0887, a member the DUF664 family of the DinB superfamily, as the MST. The identity of the M. smegmatis and homologous Mycobacterium tuberculosis (Rv0443) enzymes was confirmed by cloning, and the expressed proteins were found to be active with MSH but not bacillithiol (BSH) or glutathione (GSH). Bacillus subtilis YfiT is another member of the DinB superfamily, but this bacterium produces BSH. The YfiT protein was shown to have S-transferase activity with monochlorobimane when assayed with BSH but not with MSH or GSH. Enterococcus faecalis EF_3021 shares some homology with MSMEG_0887, but En. faecalis produces GSH but not MSH or BSH. Cloned and expressed EF_0321 was active with monochlorobimane and GSH but not with MSH or BSH. MDMPI_2 is another member of the DinB superfamily and has been previously shown to have mycothiol-dependent maleylpyruvate isomerase activity. Three of the eight families of the DinB superfamily include proteins shown to catalyze thiol-dependent metabolic or detoxification activities. Because more than two-thirds of the sequences assigned to the DinB superfamily are members of these families, it seems likely that such activity is dominant in the DinB superfamily.


Subject(s)
Cysteine/analogs & derivatives , Glucosamine/analogs & derivatives , Glutathione Transferase/chemistry , Glutathione Transferase/metabolism , Glycopeptides/metabolism , Inositol/metabolism , Amidohydrolases/chemistry , Amidohydrolases/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Bacterial Proteins/metabolism , Cloning, Molecular , Cysteine/metabolism , Enterococcus faecalis/enzymology , Glucosamine/metabolism , Multigene Family , Mycobacterium smegmatis/metabolism , Mycobacterium tuberculosis/enzymology , Phylogeny , Pyrazoles/metabolism , Sequence Homology, Amino Acid
7.
Nat Chem Biol ; 5(9): 625-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19578333

ABSTRACT

Glutathione is a nearly ubiquitous, low-molecular-mass thiol and antioxidant, but it is conspicuously absent from most Gram-positive bacteria. We identify here the structure of bacillithiol, a newly described and abundant thiol produced by Bacillus species, Staphylococcus aureus and Deinococcus radiodurans. Bacillithiol is the alpha-anomeric glycoside of L-cysteinyl-D-glucosamine with L-malic acid and most probably functions as an antioxidant. Bacillithiol, like the structurally similar mycothiol, may serve as a substitute for glutathione.


Subject(s)
Antioxidants/isolation & purification , Cysteine/analogs & derivatives , Deinococcus/metabolism , Glucosamine/analogs & derivatives , Staphylococcus aureus/metabolism , Sulfhydryl Compounds/isolation & purification , Antioxidants/chemistry , Antioxidants/pharmacology , Cysteine/chemistry , Cysteine/isolation & purification , Cysteine/pharmacology , Glucosamine/chemistry , Glucosamine/isolation & purification , Glucosamine/pharmacology , Glutathione/chemistry , Glutathione/pharmacology , Models, Molecular , Molecular Structure , Sulfhydryl Compounds/chemistry , Sulfhydryl Compounds/pharmacology
8.
Bioorg Med Chem Lett ; 21(17): 4956-9, 2011 Sep 01.
Article in English | MEDLINE | ID: mdl-21795043

ABSTRACT

CysQ is a 3'-phosphoadenosine-5'-phosphatase that dephosphorylates intermediates from the sulfate assimilation pathway of Mycobacterium tuberculosis (Mtb). Here, we demonstrate that cysQ disruption attenuates Mtb growth in vitro and decreases the biosynthesis of sulfated glycolipids but not major thiols, suggesting that the encoded enzyme specifically regulates mycobacterial sulfation.


Subject(s)
Glycolipids/biosynthesis , Mycobacterium tuberculosis/enzymology , Phosphoric Monoester Hydrolases/metabolism , Sulfates/chemistry , Chromatography, Liquid , Glycolipids/chemistry , Mycobacterium tuberculosis/growth & development
9.
Bioorg Med Chem ; 19(13): 3956-64, 2011 Jul 01.
Article in English | MEDLINE | ID: mdl-21665483

ABSTRACT

The mycothiol biosynthesis enzyme MshC catalyzes the ligation of cysteine with the pseudodisaccharide GlcN-Ins and has been identified as an essential enzyme in Mycobacterium tuberculosis. We now report on the development of NTF1836 as a micromolar inhibitor of MshC. Using commercial libraries, we conducted preliminary structure-activity relationship (SAR) studies on NTF1836. Based on this data, NTF1836 and five structurally related compounds showed similar activity towards clinical strains of M. tuberculosis. A gram scale synthesis was developed to provide ample material for biological studies. Using this material, we determined that inhibition of M. tuberculosis growth by NTF1836 was accompanied by a fall in mycothiol and an increase in GlcN-Ins consistent with the targeting of MshC. We also determined that NTF1836 kills non-replicating M. tuberculosis in the carbon starvation model of latency.


Subject(s)
Bacterial Proteins/antagonists & inhibitors , Dibenzothiazepines/chemistry , Enzyme Inhibitors/chemistry , Mycobacterium tuberculosis/enzymology , Animals , Bacterial Proteins/metabolism , Chlorocebus aethiops , Cysteine/biosynthesis , Dibenzothiazepines/chemical synthesis , Dibenzothiazepines/toxicity , Drug Evaluation, Preclinical , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/toxicity , Glycopeptides/biosynthesis , Inositol/biosynthesis , Mycobacterium tuberculosis/drug effects , Structure-Activity Relationship , Vero Cells
10.
Biochemistry ; 49(38): 8398-414, 2010 Sep 28.
Article in English | MEDLINE | ID: mdl-20799687

ABSTRACT

Bacillithiol (Cys-GlcN-malate, BSH) has recently been identified as a novel low-molecular weight thiol in Bacillus anthracis, Staphylococcus aureus, and several other Gram-positive bacteria lacking glutathione and mycothiol. We have now characterized the first two enzymes for the BSH biosynthetic pathway in B. anthracis, which combine to produce α-d-glucosaminyl l-malate (GlcN-malate) from UDP-GlcNAc and l-malate. The structure of the GlcNAc-malate intermediate has been determined, as have the kinetic parameters for the BaBshA glycosyltransferase (→GlcNAc-malate) and the BaBshB deacetylase (→GlcN-malate). BSH is one of only two natural products reported to contain a malyl glycoside, and the crystal structure of the BaBshA-UDP-malate ternary complex, determined in this work at 3.3 Å resolution, identifies several active-site interactions important for the specific recognition of l-malate, but not other α-hydroxy acids, as the acceptor substrate. In sharp contrast to the structures reported for the GlcNAc-1-d-myo-inositol-3-phosphate synthase (MshA) apo and ternary complex forms, there is no major conformational change observed in the structures of the corresponding BaBshA forms. A mutant strain of B. anthracis deficient in the BshA glycosyltransferase fails to produce BSH, as predicted. This B. anthracis bshA locus (BA1558) has been identified in a transposon-site hybridization study as required for growth, sporulation, or germination [Day, W. A., Jr., Rasmussen, S. L., Carpenter, B. M., Peterson, S. N., and Friedlander, A. M. (2007) J. Bacteriol. 189, 3296-3301], suggesting that the biosynthesis of BSH could represent a target for the development of novel antimicrobials with broad-spectrum activity against Gram-positive pathogens like B. anthracis. The metabolites that function in thiol redox buffering and homeostasis in Bacillus are not well understood, and we present a composite picture based on this and other recent work.


Subject(s)
Bacillus anthracis/enzymology , Cysteine/biosynthesis , Cysteine/metabolism , Bacillus anthracis/metabolism , Binding Sites , Borohydrides , Cysteine/analogs & derivatives , Cysteine/chemistry , Glucosamine/analogs & derivatives , Glucosamine/biosynthesis , Glucosamine/metabolism , Glycopeptides , Glycosyltransferases/biosynthesis , Glycosyltransferases/metabolism , Inositol , Intramolecular Lyases , Molecular Weight , Oxidation-Reduction , Sulfhydryl Compounds/metabolism , Uridine Diphosphate/biosynthesis , Uridine Diphosphate/metabolism
11.
Mol Microbiol ; 68(4): 805-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18430078

ABSTRACT

Mycothiol (MSH) is the major thiol in Actinobacteria and plays a role analogous to that of glutathione. The biosynthetic pathway has been established in mycobacteria and is initiated by the glycosyltransferase MshA. A key mycothiol-dependent detoxification pathway utilizes the amidase (Mca) to cleave mycothiol S-conjugates to produce GlcN-Ins and a mercapturic acid excreted from the cell. How expression of mycothiol genes is regulated in mycobacteria has been unclear so the report in this issue by Park and Roe showing that in Streptomyces coelicolor the redox controlled anti-sigma factor RsrA that binds the regulator sigma(R) controls key elements of mycothiol metabolism is a major advance. Conditions that deplete thiols are shown to induce directly expression of sigR, rsrA, mshA and mca, as well as the thioredoxin reductase-thioredoxin system, generating an autoregulatory cycle that persists until the thiol-depleting condition is alleviated. Evidence for indirect induction of mshB-D to support mycothiol biosynthesis is also presented. It was shown in vitro that mycothiol, like reduced thioredoxin and dithiothreitol, can reduce oxidized RsrA to activate its binding to sigma(R). These studies establish for the first time how mycothiol metabolism is regulated to cope with stress from thiol reactive toxins.


Subject(s)
Actinobacteria/metabolism , Bacterial Proteins/metabolism , Cysteine/genetics , Cysteine/metabolism , Gene Expression Regulation, Bacterial , Glycopeptides/genetics , Glycopeptides/metabolism , Inositol/genetics , Inositol/metabolism , Sigma Factor/metabolism , Transcription Factors/metabolism , Actinobacteria/genetics , Streptomyces coelicolor/genetics , Streptomyces coelicolor/metabolism , Sulfhydryl Compounds/metabolism
12.
Arch Microbiol ; 191(1): 89-93, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18719892

ABSTRACT

Most Actinobacteria produce mycothiol as the major thiol. In addition to mycothiol Rhodococcus AD45 generates a substantial level of glutathione possibly using genes acquired in a lateral transfer. Instead of mycothiol, Rubrobacter radiotolerans and Rubrobacter xylanophilus produce glutathione, whose synthesis appears to involve enzymes substantially different from those in other organisms.


Subject(s)
Actinobacteria/metabolism , Glutathione/metabolism , Actinobacteria/enzymology , Actinobacteria/genetics , Amino Acid Sequence , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cysteine/metabolism , Glycopeptides/metabolism , Inositol/metabolism , Molecular Sequence Data , Sequence Alignment
13.
mBio ; 10(1)2019 01 15.
Article in English | MEDLINE | ID: mdl-30647158

ABSTRACT

J. Hiras, S. V. Sharma, V. Raman, R. A. J. Tinson, et al. (mBio 9:e01603-18, 2018, https://doi.org/10.1128/mBio.01603-18) report on the identification of a novel thiol, N-methyl-bacillithiol (N-Me-BSH), in the green sulfur bacterium Chlorobium tepidum In N-methyl-bacillithiol, the amine of the cysteine is methylated by a novel S-adenosylmethioneine transferase designated N-methyl-bacillithiol synthase A (NmbA). The Hiras et al. study is significant because it is the first report of the presence of N-Me-BSH in anaerobic bacteria.


Subject(s)
Cysteine , Sulfhydryl Compounds , Bacteria, Anaerobic , Chlorobi , Cysteine/analogs & derivatives , Glucosamine/analogs & derivatives
14.
Res Microbiol ; 159(9-10): 643-50, 2008.
Article in English | MEDLINE | ID: mdl-18832026

ABSTRACT

Mycothiol (1d-myo-inosityl 2-[N-acetyl-L-cysteinyl]amido-2-deoxy-alpha-D-glucopyranoside) is an important microbial thiol present only in actinomycetes. Rhodococcus jostii RHA1 degrades a wide range of xenobiotics, including polychlorinated biphenyls, nitriles and N-nitrosodimethylamine. Analyses revealed that this strain produces two thiols, mycothiol and ergothioneine, found in the other actinomycetes. A mycothiol ligase mutant strain of R. jostii RHA1 deficient in the production of mycothiol was constructed. This mutant has a number of interesting characteristics: (a) it overproduces the intermediate glucosamine-inositol (1-O-(2-amino-1-deoxy-alpha-D-glucopyranosyl)-D-myo-inositol); (b) it is deficient in the biochemical degradation of a number of xenobiotics metabolized by the parent strain; (c) it shows increased susceptibility to a number of antibiotics; and (d) it shows unusual growth characteristics, exhibiting a long lag phase before normal exponential growth. The diverse phenotypes of the mutant indicate the utility of R. jostii RHA1 as a model for deciphering the various functions of mycothiol.


Subject(s)
Cysteine/metabolism , Glycopeptides/metabolism , Inositol/metabolism , Ligases/genetics , Mutation , Rhodococcus/enzymology , Rhodococcus/growth & development , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Culture Media , Ergothioneine/metabolism , Gene Deletion , Glucosamine/metabolism , Ligases/metabolism , Rhodococcus/classification , Rhodococcus/genetics
15.
Arch Microbiol ; 190(5): 547-57, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18629474

ABSTRACT

Marine actinomycetes have generated much recent interest as a potentially valuable source of novel antibiotics. Like terrestrial actinomycetes the marine actinomycetes are shown here to produce mycothiol as their protective thiol. However, a novel thiol, U25, was produced by MAR2 strain CNQ703 upon progression into stationary phase when secondary metabolite production occurred and became the dominant thiol. MSH and U25 were maintained in a reduced state during early stationary phase, but become significantly oxidized after 10 days in culture. Isolation and structural analysis of the monobromobimane derivative identified U25 as a homolog of mycothiol in which the acetyl group attached to the nitrogen of cysteine is replaced by a propionyl residue. This N-propionyl-desacetyl-mycothiol was present in 13 of the 17 strains of marine actinomycetes examined, including five strains of Salinispora and representatives of the MAR2, MAR3, MAR4 and MAR6 groups. Mycothiol and its precursor, the pseudodisaccharide 1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-D-myo-inositol, were found in all strains. High levels of mycothiol S-conjugate amidase activity, a key enzyme in mycothiol-dependent detoxification, were found in most strains. The results demonstrate that major thiol/disulfide changes accompany secondary metabolite production and suggest that mycothiol-dependent detoxification is important at this developmental stage.


Subject(s)
Actinobacteria/chemistry , Cysteine/chemistry , Cysteine/isolation & purification , Glycopeptides/chemistry , Glycopeptides/isolation & purification , Inositol/chemistry , Inositol/isolation & purification , Actinobacteria/enzymology , Actinobacteria/isolation & purification , Amidohydrolases/metabolism , Biosynthetic Pathways , Magnetic Resonance Spectroscopy , Molecular Structure , Oxidation-Reduction , Water Microbiology
16.
PLoS One ; 13(2): e0192977, 2018.
Article in English | MEDLINE | ID: mdl-29451913

ABSTRACT

Bacillithiol is a low molecular weight thiol found in Firmicutes that is analogous to glutathione, which is absent in these bacteria. Bacillithiol transferases catalyze the transfer of bacillithiol to various substrates. The S-transferase-like (STL) superfamily contains over 30,000 putative members, including bacillithiol transferases. Proteins in this family are extremely divergent and are related by structural rather than sequence similarity, leaving it unclear if all share the same biochemical activity. Bacillus subtilis encodes eight predicted STL superfamily members, only one of which has been shown to be a bacillithiol transferase. Here we find that the seven remaining proteins show varying levels of metal dependent bacillithiol transferase activity. We have renamed the eight enzymes BstA-H. Mass spectrometry and gene expression studies revealed that all of the enzymes are produced to varying levels during growth and sporulation, with BstB and BstE being the most abundant and BstF and BstH being the least abundant. Interestingly, several bacillithiol transferases are induced in the mother cell during sporulation. A strain lacking all eight bacillithiol transferases showed normal growth in the presence of stressors that adversely affect growth of bacillithiol-deficient strains, such as paraquat and CdCl2. Thus, the STL bacillithiol transferases represent a new group of proteins that play currently unknown, but potentially significant roles in bacillithiol-dependent reactions. We conclude that these enzymes are highly divergent, perhaps to cope with an equally diverse array of endogenous or exogenous toxic metabolites and oxidants.


Subject(s)
Bacillus subtilis/enzymology , Bacterial Proteins/metabolism , Cysteine/analogs & derivatives , Gene Expression Regulation, Bacterial , Glucosamine/analogs & derivatives , Transferases/metabolism , Bacillus subtilis/genetics , Bacillus subtilis/growth & development , Bacterial Proteins/classification , Bacterial Proteins/genetics , Cysteine/metabolism , Glucosamine/metabolism , Molecular Weight , Phylogeny , Transferases/classification , Transferases/genetics
17.
Science ; 355(6321): 194-197, 2017 01 13.
Article in English | MEDLINE | ID: mdl-28082593

ABSTRACT

We observed the assembly of a nucleus-like structure in bacteria during viral infection. Using fluorescence microscopy and cryo-electron tomography, we showed that Pseudomonas chlororaphis phage 201φ2-1 assembled a compartment that separated viral DNA from the cytoplasm. The phage compartment was centered by a bipolar tubulin-based spindle, and it segregated phage and bacterial proteins according to function. Proteins involved in DNA replication and transcription localized inside the compartment, whereas proteins involved in translation and nucleotide synthesis localized outside. Later during infection, viral capsids assembled on the cytoplasmic membrane and moved to the surface of the compartment for DNA packaging. Ultimately, viral particles were released from the compartment and the cell lysed. These results demonstrate that phages have evolved a specialized structure to compartmentalize viral replication.


Subject(s)
Pseudomonas Phages/physiology , Pseudomonas chlororaphis/virology , Virus Assembly , Capsid/metabolism , Capsid Proteins/biosynthesis , Capsid Proteins/genetics , Cryoelectron Microscopy , Cytoplasm/ultrastructure , Cytoplasm/virology , DNA, Viral/biosynthesis , Microscopy, Fluorescence , Pseudomonas Phages/genetics , Pseudomonas chlororaphis/ultrastructure , Transcription, Genetic
19.
J Antibiot (Tokyo) ; 69(5): 353-61, 2016 05.
Article in English | MEDLINE | ID: mdl-26648120

ABSTRACT

Although most clinically used antibiotics are derived from natural products, identifying new antibacterial molecules from natural product extracts is difficult due to the complexity of these extracts and the limited tools to correlate biological activity with specific molecules. Here, we show that bacterial cytological profiling (BCP) provides a rapid method for mechanism of action determination on plates and in complex natural product extracts and for activity-guided purification. We prepared an extract from Bacillus subtilis 3610 that killed the Escherichia coli lptD mutant and used BCP to observe two types of bioactivities in the unfractionated extract: inhibition of translation and permeablization of the cytoplasmic membrane. We used BCP to guide purification of the molecules responsible for each activity, identifying the translation inhibitors bacillaene and bacillaene B (glycosylated bacillaene) and demonstrating that two molecules contribute to cell permeabilitization, the bacteriocin subtilosin and the cyclic peptide sporulation killing factor. Our results suggest that bacillaene mediates translational arrest, and show that bacillaene B has a minimum inhibitory concentration 10 × higher than unmodified bacillaene. Finally, we show that BCP can be used to screen strains on an agar plate without the need for extract preparation, greatly saving time and improving throughput. Thus, BCP simplifies the isolation of novel natural products, by identifying strains, crude extracts and fractions with interesting bioactivities even when multiple activities are present, allowing investigators to focus labor-intensive steps on those with desired activities.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacillus subtilis/metabolism , Cell Membrane Permeability/drug effects , Escherichia coli/drug effects , Peptide Chain Elongation, Translational/drug effects , Bacterial Outer Membrane Proteins/genetics , Bacteriocins/metabolism , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Microbial Sensitivity Tests , Peptides, Cyclic/metabolism , Polyenes/pharmacology
20.
J Androl ; 26(5): 629-37; discussion 638-40, 2005.
Article in English | MEDLINE | ID: mdl-16088041

ABSTRACT

Sperm thiol oxidation during sperm maturation is important for sperm component stabilization, the acquisition of sperm motility, and fertilizing ability. A correct degree of oxidation is required, since spermatozoa are very susceptible to oxidative damage. The pathways involved in physiologic sperm thiol oxidation in the epididymis are not completely understood. The nonprotein thiol glutathione (GSH), in addition to playing a major role as an antioxidant and in eliminating toxic compounds, has been implicated in prooxidation processes in various cells, via gamma-glutamyl-transpeptidase (gamma-GT)-dependent catabolism. Little information is available on the dynamics of nonprotein thiols (NPSHs) and disulfides (NPSSNPs) in spermatozoa and epididymal fluid (EF) during sperm passage in the epididymis. It is not clear whether NPSHs and NPSSNPs are involved in sperm protein thiol (PSH) oxidation or whether GSH catabolism in the epididymis can serve as a pathway for sperm PSH oxidation. In the present study, we used the thiol fluorescence labeling agent monobromobimane to analyze NPSHs and nonprotein disulfides (NPSSRs) (R, nonprotein or protein) in spermatozoa and EF in the rat caput and cauda epididymis. NPSH levels are shown to be significantly higher in the caput than in the cauda (spermatozoa and fluid). GSH in the caput lumen is subject to high gamma-GT activity. A marked loss of sperm GSH and a shift to an oxidized state (resulting in a significantly higher concentration of glutathione disulfides [GSSRs] than GSH) occur during the passage of spermatozoa from the caput to the cauda epididymis. Caput EF and extracellular NPSSNPs induce sperm thiol oxidation. The results suggest that epididymal NPSH/NPSSNP participates in sperm PSH oxidation and that some reactions of GSH in the gamma-GT pathway (in the epididymis) provide oxidizing power, leading to physiologic sperm thiol oxidation.


Subject(s)
Disulfides/metabolism , Epididymis/chemistry , Semen/chemistry , Sperm Maturation/physiology , Spermatozoa/chemistry , Sulfhydryl Compounds/metabolism , gamma-Glutamyltransferase/physiology , Animals , Cysteine/metabolism , Enzyme Inhibitors/pharmacology , Glutathione/metabolism , Glutathione Disulfide/metabolism , Isoxazoles/pharmacology , Male , Models, Biological , Rats , Rats, Wistar , Sperm Head/chemistry , gamma-Glutamyltransferase/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL